Back to Home
Multimedia

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

Release Date

September 30, 2024

Expiration Date

October 1, 2025

Credits

1.0 CME, NCPD

Specialties

General Oncology, Hematologic Cancer+2 more

Release Date: September 30, 2024

Expiration Date: September 30, 2025

Activity Overview

This Expert Illustrations and CommentariesTM is a video-based program in which 2 experts discuss the emerging role of CSF-1R–directed therapy for the treatment of chronic graft-versus-host disease (GVHD). Their discussion is enriched with the use of video animations to illustrate the pathogenesis of chronic GVHD and the mechanistic rationale for targeting the CSF-1R signaling pathway. The use of an animated video helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians gain understanding of the evolving chronic GVHD treatment landscape and consider the latest data to help inform optimal sequencing decisions.

Target Audience

Blood marrow transplant specialists, medical oncologists, hematologic oncologists, hematologists, pharmacists, nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment of GVHD.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explore mechanisms of action for chronic GVHD treatment strategies including CSF-1R inhibition in the context of efficacy and safety profiles
  • Analyze recent safety and efficacy findings from trials that have evaluated emerging strategies for the treatment of chronic GVHD
  • Explain how recent trial evidence may impact the evolving treatment paradigms for patients with chronic GVHD
BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-274-H01-P. The activity is available for CE credit through September 30, 2025.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Course

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

Create Account